Evelo Biosciences Says Co. & Abdul Latif Jameel Health Entered Strategic Collaboration

April 26, 2021 | Source: Reuters
Reuters Logo


Reuters reports that Evelo Biosciences and Abdul Latif Jameel Health have entered a strategic collaboration to develop and commercialize Evelo’s novel therapy EDP1815 for inflammatory diseases and COVID-19 in select developing markets serving 1.7 billion people.  

Read the full article in its original location here.

Related Articles

For press inquiries click here, or call +971 4 448 0906 (GMT +4 hours UAE). For public inquiries click here.

Contact Us

Abdul Latif Jameel Health

W www.aljhealth.com

Follow Us

  • Linkedin
  • Facebook
  • instagram
  • Youtube
 col transparent